These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26886644)

  • 1. Differences and Similarities in the Clinicopathological Features of Pancreatic Neuroendocrine Tumors in China and the United States: A Multicenter Study.
    Zhu LM; Tang L; Qiao XW; Wolin E; Nissen NN; Dhall D; Chen J; Shen L; Chi Y; Yuan YZ; Ben QW; Lv B; Zhou YR; Bai CM; Chen J; Song YL; Song TT; Lu CM; Yu R; Chen YJ
    Medicine (Baltimore); 2016 Feb; 95(7):e2836. PubMed ID: 26886644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumors: A Retrospective Nationwide Multicenter Study in South Korea.
    Cho JH; Ryu JK; Song SY; Hwang JH; Lee DK; Woo SM; Joo YE; Jeong S; Lee SO; Park BK; Cheon YK; Han J; Kim TN; Lee JK; Moon SH; Kim H; Park ET; Hwang JC; Kim TH; Jeon TJ; Cho CM; Choi HS; Lee WJ
    Pancreas; 2016 Aug; 45(7):941-6. PubMed ID: 26765964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
    Yadav S; Sharma P; Zakalik D
    Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome and long-term survival of 150 consecutive patients with pancreatic neuroendocrine tumors: A comprehensive analysis by the World Health Organization 2010 grading classification.
    Deng BY; Liu F; Yin SN; Chen AP; Xu L; Li B
    Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):261-268. PubMed ID: 29307515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
    Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
    Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
    Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
    BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.
    Kuo EJ; Salem RR
    Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival.
    Halfdanarson TR; Rabe KG; Rubin J; Petersen GM
    Ann Oncol; 2008 Oct; 19(10):1727-33. PubMed ID: 18515795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
    Fang C; Wang W; Zhang Y; Feng X; Sun J; Zeng Y; Chen Y; Li Y; Chen M; Zhou Z; Chen J
    Chin J Cancer; 2017 Jun; 36(1):51. PubMed ID: 28637502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavior of Small, Asymptomatic, Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PNETs).
    Jung JG; Lee KT; Woo YS; Lee JK; Lee KH; Jang KT; Rhee JC
    Medicine (Baltimore); 2015 Jul; 94(26):e983. PubMed ID: 26131843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior.
    Morin E; Cheng S; Mete O; Serra S; Araujo PB; Temple S; Cleary S; Gallinger S; Greig PD; McGilvray I; Wei A; Asa SL; Ezzat S
    Cancer Med; 2013 Oct; 2(5):701-11. PubMed ID: 24403235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Validity of the American Joint Committee on Cancer Eighth Edition TNM Staging System for Surgically Treated and Well-Differentiated Pancreatic Neuroendocrine Tumors: A Comprehensive Analysis of 254 Consecutive Patients From a Large Chinese Institution.
    Yang M; Zhang Y; Zeng L; Ke NW; Tan CL; Tian BL; Xiang B; Liu XB
    Pancreas; 2019; 48(5):613-621. PubMed ID: 31091206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic neuroendocrine tumours: Grade is superior to T, N, or M status in predicting outcome and selecting patients for chemotherapy:A retrospective cohort study in the SEER database.
    Zhai H; Li D; Feng Q; Qian X; Li L; Yao J
    Int J Surg; 2019 Jun; 66():103-109. PubMed ID: 30872175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological characteristics of non-functioning cystic pancreatic neuroendocrine tumors.
    Nakashima Y; Ohtsuka T; Nakamura S; Mori Y; Nakata K; Miyasaka Y; Ishigami K; Matsuda R; Oda Y; Nakamura M
    Pancreatology; 2019 Jan; 19(1):50-56. PubMed ID: 30497875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics and Prognostic Factors of Early-Onset Pancreatic Neuroendocrine Tumors.
    Shi M; Zhou B
    Cancer Control; 2021; 28():1073274820986827. PubMed ID: 33491476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and body/tail pancreatic neuroendocrine tumors have different biological characteristics and clinical outcomes.
    Mei W; Ding Y; Wang S; Jia Y; Cao F; Li F
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):3049-3061. PubMed ID: 32601815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological characteristics and prognosis-related factors of resectable pancreatic neuroendocrine tumors: a retrospective study of 104 cases in a single Chinese center.
    Han X; Xu X; Jin D; Wang D; Ji Y; Lou W
    Pancreas; 2014 May; 43(4):526-31. PubMed ID: 24658317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic neuroendocrine tumors: Nosography, management and treatment.
    Orditura M; Petrillo A; Ventriglia J; Diana A; Laterza MM; Fabozzi A; Savastano B; Franzese E; Conzo G; Santini L; Ciardiello F; De Vita F
    Int J Surg; 2016 Apr; 28 Suppl 1():S156-62. PubMed ID: 26708853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic Pancreatic Neuroendocrine Tumors Represent a Distinct Clinical Entity with Less Aggressive Biological Behaviors.
    Cheng Y; Wu D; Wang L; Liu H; Xiong Y; Xu J; Hu S; Zhan H
    J Surg Res; 2021 Apr; 260():134-140. PubMed ID: 33340866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reassessment of the current American Joint Committee on Cancer staging system for pancreatic neuroendocrine tumors.
    Qadan M; Ma Y; Visser BC; Kunz PL; Fisher GA; Norton JA; Poultsides GA
    J Am Coll Surg; 2014 Feb; 218(2):188-95. PubMed ID: 24321190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.